Skip to main content
. 2017 Sep 7;60(12):2361–2367. doi: 10.1007/s00125-017-4424-y

Table 2.

 Numbers and intervals of the screening examinations on the study participants

Variable All patients Patients with progression Patients without progression
Screening period (years) 12.88 (1.89) 12.52 (1.96) 13.24 (1.75)
Number of visits 7.48 (2.57) 7.97 (2.48) 7.00 (2.60)
Screening interval (years) 1.72 (0.64) 1.57 (0.55) 1.89 (0.74)

Data are presented as means ± SD